RxDoctor Payments Data
★ My doctorsLook up a doctor →

Sejal Kadam, MD

Internal Medicine · Hicksville, NYNPI 1083659304

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 357 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 44.2% of the total. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,282in general payments, 2019–2025

Across 357 payments — averaging $34.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • QOL Medical, LLC$894
  • Amgen$585
  • Redhill Biopharma Inc.$397
  • Ironwood Pharmaceuticals, Inc$390
  • plus $3K from 25 others

What the payments were for

  • Food & beverage$12,16799%
  • Education$150%
  • Gifts$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie116$5,426
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC72$1,209
QOL Medical, LLC30$894
Amgen(2 entities)5$585
Redhill Biopharma Inc.17$397
Ironwood Pharmaceuticals, Inc23$390
Intra-sana Laboratories4$389
Ardelyx, Inc.16$346
Sanofi4$294
Novo Nordisk2$273
Lilly USA, LLC7$254
Johnson & Johnson11$239
Madrigal Pharmaceuticals5$232
Braintree Laboratories, Inc.7$177
Merck7$133
GSK1$128
Bristol Myers Squibb1$125
Phathom Pharmaceuticals, Inc.6$123
UCB, Inc.2$123
Novartis1$116
Aimmune Therapeutics, Inc.3$73
Vivus LLC3$61
Ferring Pharmaceuticals Inc.2$49
Intercept Pharmaceuticals, Inc.2$45
Cumberland Pharmaceuticals, Inc.2$45
Evoke Pharma, Inc.2$43
Endo Pharmaceuticals Inc.2$31
Takeda Pharmaceuticals U.S.A., Inc.1$23
Daiichi Sankyo Inc.1$22
Valinor Pharma, LLC1$20
Enterra Medical, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,282 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Medicare billing

Part B allowed, 2024
$111,539
Medicare patients
162
Services billed
857

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Furosemide11$23
Amlodipine Besylate17$16

Paid to pharmacies, not to this prescriber.

Other internal medicine in Hicksville

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →